We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+11.35%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$81.6B
AUM Growth
+$7.7B
Cap. Flow
+$798M
Cap. Flow %
0.98%
Top 10 Hldgs %
23.85%
Holding
3,095
New
53
Increased
1,513
Reduced
1,408
Closed
84

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$65.3M
2
AMZN icon
Amazon
AMZN
+$50M
3
TSLA icon
Tesla
TSLA
+$30.5M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$26.6M
5
EPAM icon
EPAM Systems
EPAM
+$26.3M

Top Sells

Rank Stock Value
1
KSU
Kansas City Southern
KSU
+$39.1M
2
HRC
HILL-ROM HOLDINGS, INC.
HRC
+$31.2M
3
XEC
CIMAREX ENERGY CO
XEC
+$23.4M
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$21.9M
5
SBNY
Signature Bank
SBNY
+$17.7M

Sector Composition

Rank Sector Weight
1 Technology 25.54%
2 Financials 13.15%
3 Healthcare 12.95%
4 Consumer Discretionary 12.27%
5 Industrials 8.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MBII
2976
DELISTED
Marrone Bio Innovations, Inc.
MBII
$52K ﹤0.01%
72,447
-492
-0.7% -$398
GTBP icon
2977
GT Biopharma
GTBP
$10.9M
$51K ﹤0.01%
556
– –
SHCR
2978
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
$51K ﹤0.01%
11,337
– –
TLIS
2979
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
$50K ﹤0.01%
839
– –
PLM
2980
DELISTED
PolyMet Mining Corp.
PLM
$50K ﹤0.01%
19,971
+3,177
+19% +$9.68K
HYRE
2981
DELISTED
HyreCar Inc. Common Stock
HYRE
$49K ﹤0.01%
10,501
-653
-6% -$4.08K
NEXI
2982
DELISTED
NexImmune, Inc. Common Stock
NEXI
$46K ﹤0.01%
401
-12
-3% -$2.88K
TISI icon
2983
Team
TISI
$77.5M
$43K ﹤0.01%
3,990
-50
-1% -$998
TLMD
2984
DELISTED
SOC Telemed, Inc. Class A Common Stock
TLMD
$42K ﹤0.01%
32,907
-34
-0.1% -$68
KLTR icon
2985
Kaltura
KLTR
$264M
$41K ﹤0.01%
12,070
-327
-3% -$2.17K
KLDO
2986
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
$39K ﹤0.01%
16,193
+5,818
+56% +$23.7K
LFWD icon
2987
ReWalk Robotics
LFWD
$20.8M
$38K ﹤0.01%
368
– –
AFIB
2988
DELISTED
Acutus Medical Inc
AFIB
$38K ﹤0.01%
11,190
+100
+0.9% +$563
HIPO icon
2989
Hippo Holdings
HIPO
$875M
$35K ﹤0.01%
+494
New +$46K
HOOK
2990
DELISTED
HOOKIPA Pharma
HOOK
$34K ﹤0.01%
1,474
-10
-0.7% -$402
SMMT icon
2991
Summit Therapeutics
SMMT
$10.9B
$34K ﹤0.01%
12,823
-603
-4% -$2.9K
ELTX icon
2992
Elicio Therapeutics
ELTX
$82.2M
$32K ﹤0.01%
1,095
– –
BLRX
2993
BioLineRX
BLRX
$12.4M
$30K ﹤0.01%
364
– –
SGTX
2994
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
$30K ﹤0.01%
+841
New +$47.9K
NH
2995
DELISTED
NantHealth, Inc
NH
$23K ﹤0.01%
1,465
+1
+0.1% +$21
AAOI icon
2996
Applied Optoelectronics
AAOI
$11.1B
– –
-33,543
Closed -$241K
ABEV icon
2997
Ambev
ABEV
$46.7B
– –
-20,890
Closed -$58K
ASML icon
2998
ASML
ASML
$672B
– –
-534
Closed -$398K
ASX icon
2999
ASE Group
ASX
$83B
– –
-18,978
Closed -$149K
BABA icon
3000
Alibaba
BABA
$305B
– –
-2,310
Closed -$342K
118 119
120
121 122

Similar funds

VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

RhumbLine Advisers's Q4 2021 Portfolio in Review

As of Q4 2021, RhumbLine Advisers held 3,095 positions worth $81.6B, up 10% from $73.9B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Trading was light in Q4 2021: portfolio turnover was 4.4%. RhumbLine Advisers opened 53 new positions and exited 84, leaving the 3,095-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q4 2021 buy was Rivian: 125,331 shares worth $13M.
  • RhumbLine Advisers added most to Microsoft in Q4 2021, an estimated $65.3M increase.
  • RhumbLine Advisers's biggest Q4 2021 reduction was Berkshire Hathaway Class B, cutting an estimated $21.9M.
  • RhumbLine Advisers fully exited Kansas City Southern in Q4 2021, selling an estimated $39.1M.
  • RhumbLine Advisers's ten largest holdings make up 24% of its $81.6B portfolio in Q4 2021.
  • RhumbLine Advisers opened 53 new positions and closed 84 in Q4 2021.
  • RhumbLine Advisers's portfolio value rose 10% quarter-over-quarter to $81.6B.

Based on RhumbLine Advisers's 13F filing for Q4 2021, filed 10 Feb 2022.